Free Trial
ASX:CUV

Clinuvel Pharmaceuticals (CUV) Stock Price, News & Analysis

Clinuvel Pharmaceuticals logo

About Clinuvel Pharmaceuticals Stock (ASX:CUV)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
124,193 shs
Average Volume
N/A
Market Capitalization
A$563.18 million
P/E Ratio
15.95
Dividend Yield
0.44%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CUV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Clinuvel Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

CUV Stock News Headlines

Undervalued ASX biotech
Miss This Window And You Miss Everything
There’s a moment in every crypto cycle when everything just clicks — and that moment is now. This is the phase when momentum builds, news turns bullish, and markets ignite. Inside The Crypto Code Workshop, you’ll get the roadmap to ride this wave — and $10 in free Bitcoin just for showing up.
Clinuvel Pharmaceuticals Stock Price History
High Growth Tech Stocks In Australia For March 2025
See More Headlines

CUV Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that Clinuvel Pharmaceuticals investors own include Cochlear (COH), CSL (CSL), ResMed (RMD), ARB (ARB), Accent Group (AX1), Corporate Travel Management (CTD) and Mineral Resources (MIN).

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
ASX:CUV
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
A$0.70
Trailing P/E Ratio
15.95
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
A$35.64 million
Net Margins
40.67%
Pretax Margin
N/A
Return on Equity
18.67%
Return on Assets
14.29%

Debt

Debt-to-Equity Ratio
0.43
Current Ratio
8.81
Quick Ratio
10.03

Sales & Book Value

Annual Sales
A$88.18 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
19.36
Book Value
A$4.02 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
50,060,000
Free Float
N/A
Market Cap
A$563.18 million
Optionable
Not Optionable
Beta
0.92
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (ASX:CUV) was last updated on 7/18/2025 by MarketBeat.com Staff
From Our Partners